  | Haag, M., Lehmann, A., Hersberger, K. E., Schneider, M.-P., Gauchet, A., Vrijens, B., Arnet, I., & Allenet, B. (April 2020). The ABC taxonomy for medication adherence translated into French and German. British Journal of Clinical Pharmacology, 86 (4), 734 - 744. doi:10.1111/bcp.14172  Peer Reviewed verified by ORBi |
 | Tessier, A., Dupuis, M., Baylé, F. J., Herse, C., Lange, A.-C., Vrijens, B., Schweitzer, P., Swendsen, J., & Misdrahi, D. (March 2020). Brief interventions for improving adherence in schizophrenia: A pilot study using electronic medication event monitoring. Psychiatry Research, 285. doi:10.1016/j.psychres.2020.112780 Peer Reviewed verified by ORBi |
 | Vrijens, B. (August 2019). A Six Sigma framework to successfully manage medication adherence. British Journal of Clinical Pharmacology, 85 (8), 1661 - 1663. doi:10.1111/bcp.13905 Peer Reviewed verified by ORBi |
  | Hiligsmann, M., Cornelissen, D., Vrijens, B., Abrahamsen, B., Al-Daghri, N., Biver, E., Brandi, M. L., Bruyère, O., Burlet, N., Cooper, C., Cortet, B., Dennison, E., Diez-Perez, A., Gasparik, A., Grosso, A., Hadji, P., Halbout, P., Kanis, J. A., Kaufman, J. M., ... Reginster, J.-Y. (2019). Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF). Osteoporosis International, 30 (11), 2155-2165. doi:10.1007/s00198-019-05104-5 Peer Reviewed verified by ORBi |
 | Misdrahi, D., Tessier, A., Husky, M., Lange, A.-C., Vrijens, B., Llorca, P.-M., & Baylé, F. J. (March 2018). Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS®): A six-month post-discharge prospective study. Schizophrenia Research, 193, 114-118. doi:10.1016/j.schres.2017.06.026 Peer Reviewed verified by ORBi |
 | Vrijens, B., Antoniou, S., Burnier, M., de la Sierra, A., & Volpe, M. (2017). Current Situation of Medication Adherence in Hypertension. Frontiers in Pharmacology, 8 (MAR), 100. doi:10.3389/fphar.2017.00100 Peer Reviewed verified by ORBi |
 | Michaud, L., Ludwig, G., Berney, S., Rodrigues, S., Niquille, A., Santschi, V., Favre, A.-S., Lange, A.-C., Michels, A., Vrijens, B., Bugnon, O., Pilon, N., Pascual, E., Venetz, J.-P., Stiefel, F., & Schneider, M.-P. (December 2016). Immunosuppressive therapy after solid-organ transplantation: does the INTERMED identify patients at risk of poor adherence? Pharmacy Practice, 14 (4). doi:10.18549/PharmPract.2016.04.822 Peer Reviewed verified by ORBi |
 | Vrijens, B., Dima, A. L., Van Ganse, E., van Boven, J. F. M., Eakin, M. N., Foster, J. M., de Bruin, M., Chisholm, A., & Price, D. (2016). What We Mean When We Talk About Adherence in Respiratory Medicine. Journal of Allergy and Clinical Immunology: In Practice, 4 (5), 802 - 812. doi:10.1016/j.jaip.2016.05.019 Peer Reviewed verified by ORBi |
 | Vrijens, B., Claeys, M. J., LEGRAND, V., Vandendriessche, E., & Van De Werf, F. (May 2014). Projected inhibition of platelet aggregation with ticagrelor twice daily vs. clopidogrel once daily based on patient adherence data (the TWICE project). British Journal of Clinical Pharmacology, 77 (5), 746-755. doi:10.1111/bcp.12275 Peer Reviewed verified by ORBi |
 | Wessels, A. M., Jin, Y., Pollock, B. G., Frank, E., Lange, A.-C., Vrijens, B., Fagiolini, A., Kupfer, D. J., Rucci, P., Kepple, G., Anderton, J., Buttenfield, J., & Bies, R. R. (November 2012). Adherence to escitalopram treatment in depression: a study of electronically compiled dosing histories in the 'Depression: the search for phenotypes' study. International Clinical Psychopharmacology, 27 (6), 291-7. doi:10.1097/YIC.0b013e3283597678 Peer Reviewed verified by ORBi |
 | Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., Matyjaszczyk, M., Mshelia, C., Clyne, W., Aronson, J. K., Urquhart, J., & ABC Project Team. (May 2012). A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology, 73 (5), 691 - 705. doi:10.1111/j.1365-2125.2012.04167.x Peer Reviewed verified by ORBi |
 | Comté, L., Vansteelandt, S., Rode, R., & Vrijens, B. (2011). Estimation of HIV treatment-efficacy by combining structural nested mean models with pharmacokinetic models of antiretroviral drug exposure. Statistics and Its Interface, 4 (4), 511-520. doi:10.4310/SII.2011.v4.n4.a9 Peer reviewed |
 | Cooper, V., Horne, R., Gellaitry, G., Vrijens, B., Lange, A.-C., Fisher, M., & White, D. (March 2010). The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study. Journal of acquired immune deficiency syndromes (1999), 53 (3), 369-77. doi:10.1097/QAI.0b013e3181ccb762 Peer reviewed |
 | Comté, L., Vrijens, B., Tousset, E., Gérard, P., & Urquhart, J. (August 2007). Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics. Journal of Pharmacokinetics and Pharmacodynamics, 34 (4), 549-558. doi:10.1007/s10928-007-9058-0 Peer Reviewed verified by ORBi |
Vrijens, B., & Goetghebeur, E. (September 1999). The impact of compliance in pharmacokinetic studies. Statistical Methods in Medical Research, 8 (3), 247-62. doi:10.1177/096228029900800305 Peer Reviewed verified by ORBi |
 | Faymonville, M.-E., Mambourg, P. H., Joris, J., Vrijens, B., Fissette, J., Albert, A., & Lamy, M. (December 1997). Psychological Approaches During Conscious Sedation. Hypnosis Versus Stress Reducing Strategies: A Prospective Randomized Study. Pain, 73 (3), 361-7. doi:10.1016/S0304-3959(97)00122-X Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Albert, A., Deroisy, R., Collette, J., Vrijens, B., Blacker, C., Brion, N., Caulin, F., Mayolle, C., Regnard, A., Scholler, R., & Franchimont, P. (June 1997). Plasma Estradiol Concentrations and Pharmacokinetics Following Transdermal Application of Menorest 50 or Systen (Evorel) 50. Maturitas, 27 (2), 179-86. doi:10.1016/S0378-5122(97)00027-3 Peer Reviewed verified by ORBi |
 | Scuvée-Moreau, J., Seutin, V., Vrijens, B., Pirotte, B., De Tullio, P., Massotte, L., Albert, A., Delarge, J., & Dresse, A. (1997). Effect of potassium channel openers on the firing rate of hippocampal pyramidal cells and A10 dopaminergic neurons in vitro. Archives of Physiology and Biochemistry, 105 (5), 421-8. doi:10.1076/apab.105.5.421.3285 Peer Reviewed verified by ORBi |
Hans, P., Deby, C., Deby-Dupont, G., Vrijens, B., Albert, A., & Lamy, M. (April 1996). Effect of Propofol on in Vitro Lipid Peroxidation Induced by Different Free Radical Generating Systems: A Comparison with Vitamin E. Journal of Neurosurgical Anesthesiology, 8 (2), 154-8. doi:10.1097/00008506-199604000-00010 Peer Reviewed verified by ORBi |
 | Reginster, J.-Y., Albert, A., Deroisy, R., Collette, J., Vrijens, B., Blacker, C., Brion, N., Caulin, F., Mayolle, C., Regnard, A., Sholler, R., & Franchimont, P. (1996). Plasma Concentration of Estradiol Following Transdermal Administration of Systen 50 or Menorest 50. Scandinavian Journal of Rheumatology. Supplement, 103, 94-8, discussion 99-100. doi:10.3109/03009749609103761 Peer Reviewed verified by ORBi |
